A few years ago, I was in a small group making a presentation to pharmaceutical executives. Their company manufactured a medication that dominated a psychiatric market. Several academic psychiatrists proposed a program to enhance recognition of that disorder and raise overall medication adherence.
From the Editors
Are you a healthcare provider?
Add your NPI to personalize your JCP experience.
This PDF is free for all visitors!